Protalix BioTherapeutics to Showcase Innovations at Nasdaq's BioConnect Conference Protalix BioTherapeutics will participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq New York, showcasing their pioneering biopharmaceutical advancements.

Protalix BioTherapeutics to Showcase Innovations at Nasdaq's BioConnect Conference #United_States #New_York_City #FDA_Approval #Protalix_BioTherapeutics #BioConnect_Conference